
Exploratory retrospective study of risk factors for thromboembolism treated with multi-kinase inhibitor pazopanib or lenvatinib
Author(s) -
Kenta Nio,
Kazufumi Tsuchihashi,
Keisuke Taguchi,
Tomoyasu Yoshihiro,
Kyoko Yamaguchi,
Mamoru Ito,
Shuji Moriyama,
Mitsuhiro Fukata,
Toshifumi Fujiwara,
Nokitaka Setsu,
Makoto Endo,
Yoshihiro Matsumoto,
Yasuharu Nakashima,
Takahiro Wakasaki,
Ryuji Yasumatsu,
Hiroshi Ariyama,
Hitoshi Kusaba,
Junji Kishimoto,
Koichi Akashi,
Eishi Baba
Publication year - 2020
Publication title -
international journal of surgery. oncology
Language(s) - English
Resource type - Journals
ISSN - 2471-3864
DOI - 10.1097/ij9.0000000000000089
Subject(s) - lenvatinib , medicine , pazopanib , oncology , confidence interval , capecitabine , risk factor , cancer , surgery , thyroid cancer , sunitinib , colorectal cancer